Off-label and unlicensed prescribing in Europe: implications for patients’ informed consent and liability

Montgomery and informed consent: where are we now?

(2017) Sarah W Chan et al.   BMJ-British Medical Journal

Montgomery and informed consent: where are we now?

(2017) Sarah W Chan et al.   BMJ-British Medical Journal

The New Era of Informed Consent

(2016) Erica S. Spatz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Off-label Drug Use and Adverse Drug Events in an Adult Population

(2016) Tewodros Eguale et al.   JAMA Internal Medicine

Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects

(2015) Lise Aagaard   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Ethical and legal framework and regulation for off-label use: European perspective

(2014) Christian Lenk et al.   Therapeutics and Clinical Risk Management